Your browser doesn't support javascript.
loading
Reduction and prevention of agitation in persons with neurocognitive disorders: an international psychogeriatric association consensus algorithm.
Cummings, Jeffrey; Sano, Mary; Auer, Stefanie; Bergh, Sverre; Fischer, Corinne E; Gerritsen, Debby; Grossberg, George; Ismail, Zahinoor; Lanctôt, Krista; Lapid, Maria I; Mintzer, Jacobo; Palm, Rebecca; Rosenberg, Paul B; Splaine, Michael; Zhong, Kate; Zhu, Carolyn W.
Afiliação
  • Cummings J; Joy Chambers-Grundy Professor of Brain Science, Chambers-Grundy Center for Transformative Neuroscience, Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV), USA.
  • Sano M; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, NYC NY and James J. Peters VAMC, Bronx, NY, USA.
  • Auer S; Centre for Dementia Studies, University for Continuing Education Krems, Austria.
  • Bergh S; The Research Centre for Age-Related Functional Decline and Disease, Innlandet Hospital Trust, Ottestad, Norway.
  • Fischer CE; Faculty of Medicine, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
  • Gerritsen D; Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute for Health Sciences, Radboud Alzheimer Center, Nijmegen, the Netherlands.
  • Grossberg G; Department of Psychiatry & Behavioral Neuroscience, Division of Geriatric Psychiatry, St Louis University School of Medicine, St Louis, MO, USA.
  • Ismail Z; Departments Psychiatry, Neurology, Epidemiology, and Pathology, Hotchkiss Brain Institute & O'Brien Institute for Public Health, University of Calgary, Alberta, Canada.
  • Lanctôt K; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute; and Departments of Psychiatry and Pharmacology/Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Lapid MI; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Mintzer J; Ralph. H. Johnson VA Medical Center, Charleston, SC and College of Health Professions, Medical University of South Carolina, Charleston, SC, USA.
  • Palm R; Department of Nursing Science, Faculty of Health, Witten/Herdecke University, 58455 Witten, Germany.
  • Rosenberg PB; Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Splaine M; Owner Splaine Consulting, Managing Partner, Recruitment Partners LLC, Columbia, MD, USA.
  • Zhong K; Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas, NV, USA.
  • Zhu CW; Department of Geriatrics and Palliative Medicine, Icahn School of Medicine, NYC, NY and James J. Peters VAMC, Bronx, NY, USA.
Int Psychogeriatr ; 36(4): 251-262, 2024 Apr.
Article em En | MEDLINE | ID: mdl-36876335
OBJECTIVES: To develop an agitation reduction and prevention algorithm is intended to guide implementation of the definition of agitation developed by the International Psychogeriatric Association (IPA). DESIGN: Review of literature on treatment guidelines and recommended algorithms; algorithm development through reiterative integration of research information and expert opinion. SETTING: IPA Agitation Workgroup. PARTICIPANTS: IPA panel of international experts on agitation. INTERVENTION: Integration of available information into a comprehensive algorithm. MEASUREMENTS: None. RESULTS: The IPA Agitation Work Group recommends the Investigate, Plan, and Act (IPA) approach to agitation reduction and prevention. A thorough investigation of the behavior is followed by planning and acting with an emphasis on shared decision-making; the success of the plan is evaluated and adjusted as needed. The process is repeated until agitation is reduced to an acceptable level and prevention of recurrence is optimized. Psychosocial interventions are part of every plan and are continued throughout the process. Pharmacologic interventions are organized into panels of choices for nocturnal/circadian agitation; mild-moderate agitation or agitation with prominent mood features; moderate-severe agitation; and severe agitation with threatened harm to the patient or others. Therapeutic alternatives are presented for each panel. The occurrence of agitation in a variety of venues-home, nursing home, emergency department, hospice-and adjustments to the therapeutic approach are presented. CONCLUSIONS: The IPA definition of agitation is operationalized into an agitation management algorithm that emphasizes the integration of psychosocial and pharmacologic interventions, reiterative assessment of response to treatment, adjustment of therapeutic approaches to reflect the clinical situation, and shared decision-making.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Neurocognitivos / Psiquiatria Geriátrica Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Neurocognitivos / Psiquiatria Geriátrica Idioma: En Ano de publicação: 2024 Tipo de documento: Article